Q1 2014
Released May 13, 2014, before the open
10-Q filed May 13, 2014, 43 days after period end · 0001144204-14-029745
Q1 2014 · 10-Q
Revenue—
Net Income-$5.27M-$5.27M N/M vs Q1 2013N/M vs Q4 2013
EPS Diluted-$0.41-$0.41 N/M vs Q1 2013no prior Q4 2013 on file
Operating Income-$5,292,622N/M
Operating Cash Flow-$3,217,654N/M
Free Cash Flowderived-$3,219,520N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|
| Net Income | -$5.27M | -$1.35M | -$61.23K |
| EPS Diluted | -$0.41 | -$0.30 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR